Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Classificação em ações #13233
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Preço da ação
$4.99
Valor de mercado
$508.03M
Variação (1 dia)
-2.48%
Variação (1 ano)
2.10%
País
TW
Negociar Ever Supreme Bio Technology Co., Ltd (6712)

Categoria

Histórico de preços das ações de Ever Supreme Bio Technology Co., Ltd (6712)
Preço de fecho mais alto: $4.88 em 2026-08-01

Preço de fecho mais baixo: $1.98 em 2018-10-01
Histórico de preços das ações da Ever Supreme Bio Technology Co., Ltd de 2018 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -4.84%
2025 8.48%
2024 -5.27%
2023 0.33%
2022 -5.52%
2021 21.39%
2020 20.06%
2019 82.02%
2018 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$539.80 38.05%
US
$1.02K 42.98%
NL
$121.01 -13.08%
AU
$141.65 488.00%
US
$749.90 5.87%
CH